Prior to commencing his academic career, Dr Brocks worked as a pharmacist in hospital and community pharmacies in Alberta, and after receipt of his MPharm degree, as Clinical Coordinator at the Rockyview Hospital Pharmacy department in Calgary. He received his doctoral degree in Pharmaceutical Sc...
Prior to commencing his academic career, Dr Brocks worked as a pharmacist in hospital and community pharmacies in Alberta, and after receipt of his MPharm degree, as Clinical Coordinator at the Rockyview Hospital Pharmacy department in Calgary. He received his doctoral degree in Pharmaceutical Sciences, specializing in Pharmacokinetics, from the University of Alberta in 1993. He was employed by the Department of Drug Metabolism and Pharmacokinetics at SmithKline Beecham Pharmaceutical from 1993 to late 1995, after which he took a position as Assistant Professor at the University of Saskatchewan.
In 1998, he joined the faculty at the Western University of Health Sciences in Pomona CA (suburban Los Angeles) as Associate Professor of Pharmaceutical Sciences. He taught pharmacokinetics and pursued his research interests there until January 2002, when he returned to his alma mater as Associate Professor of Pharmaceutical Sciences. Dr. Brocks has published over 100 peer-reviewed manuscripts related to pharmacokinetics, and has numerous published abstracts. He is on or has served with the editorial boards of the Journal of Clinical Pharmacology, Biopharmaceutics and Drug Disposition, and the Journal of Pharmacy and Pharmaceutical Sciences.
Dr Brocks in interested in the pharmacokinetics and dynamics of drugs. Many of his works have focused on stereoselectivity in the pharmacokinetics of chiral drugs that are administered as equal proportions of two enantiomers (the racemate). These drugs include nonsteroidal anti-inflammatory drugs, anticholinergic drugs and antimalarial drugs. Over the past 12 years he has pursued the study of the effects of lipids and lipoproteins on the pharmacokinetics of drugs. A more recent focus is on the effects of obesity and its treatment on drug pharmacokinetics.